Get started
Author

Nicole Mavingire

Observed name: Nicole Ursula Mavingire
ORCID: 0000-0003-1485-0519
Observed ORCID: 0000-0003-1485-0519
OpenAlex ID: A5073781081
AhR ligand aminoflavone suppresses α6‐integrin–Src–Akt signaling to attenuate tamoxifen resistance in breast cancer cells
2018 · Petreena S. Campbell, Nicole Mavingire, et al. · Journal of Cellular Physiology · 48
PDF
Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification
2024 · Sana Hachem, Amani Yehya, et al. · Biology · 32
PDF
The complex interplay of modifiable risk factors affecting prostate cancer disparities in African American men
2024 · Jabril R. Johnson, Nicole Mavingire, et al. · Nature Reviews Urology · 28
PDF
Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand–mediated triple negative breast cancer cell death
2018 · Leah K. Rowland, Petreena S. Campbell, et al. · Journal of Cellular Biochemistry · 20
Cancer stem cells: Culprits in endocrine resistance and racial disparities in breast cancer outcomes
2020 · Nicole Mavingire, Petreena Campbell, et al. · Cancer Letters · 14
Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics
2024 · Nicole Mavingire, Janelle C. Moore, et al. · Cancers · 9
PDF
Triumphs and challenges in exploiting poly(ADP‐ribose) polymerase inhibition to combat triple‐negative breast cancer
2023 · Jonathan Wooten, Nicole Mavingire, et al. · Journal of Cellular Physiology · 6
PDF
Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells
2022 · Jonathan Wooten, Nicole Mavingire, et al. · Fitoterapia · 5
Aminoflavone upregulates putative tumor suppressor miR-125b-2-3p to inhibit luminal A breast cancer stem cell-like properties
2022 · Nicole Mavingire, Petreena Campbell, et al. · Precision Clinical Medicine · 5
PDF
Abstract 898: HER2 as a therapeutic target in prostate cancer: Multi-omic and spatial insights across genetic ancestries.
2026 · Nicole Mavingire, Abdulrahman M. Dwead, et al. · Cancer Research
Spatially resolved HER2 and AR expression in prostate cancer and its implications for HER2 as a distinct therapeutic target.
2026 · Leanne Woods-Burnham, Abdulrahman Dwead, et al. · Journal of Clinical Oncology
PDF
813 HER2 Expression in Prostate Carcinoma: Association with Gleason Score and Cribriform Morphology
2026 · Ekta Jain, Nicole Mavingire, et al. · Laboratory Investigation
Abstract A075: HER2 as an Ancestry-associated Therapeutic Target in Prostate Cancer
2026 · Leanne Woods-Burnham, Nicole Mavingire, et al. · Cancer Research
Abstract B041: Community-based prostate cancer screening for Black men
2024 · Pam Cooper, Kitty Carter-Wicker, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract 1955: HER2 expression in African American men with prostate cancer
2023 · Nicole Ursula Mavingire, Mya Walker, et al. · Cancer Research
Abstract 3863: Aminoflavone confers activity against aromatase inhibitor-resistant breast cancer cells in part via miR125b2-3p restoration
2023 · Eileen J. Brantley, Nicole Mavingire, et al. · Cancer Research
Abstract PO-110: Plant isolate dibenzyl trisulfide induces caspase-independent death in triple negative breast cancer cells derived from patients of West African descent
2022 · Jonathan Wooten, Shaniece Wooten, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract 6553: Plant power: Plant isolate dibenzyl trisulfide induces death of triple-negative breast cancer cells derived from an African American patient
2020 · Jonathan Wooten, Cristina Araújo, et al. · Cancer Research
Abstract C126: Plant isolate dibenzyl trisulfide potently inhibits cytochrome P450 1 enzyme activity and the growth of breast cancer cells derived from African American patients
2020 · Jonathan V. Wooten, Shaniece Wauchope, et al. · Cancer Epidemiology Biomarkers & Prevention
Abstract 16: 3,3'-diindolylmethane induces cytoglobin expression and synergizes with poly ADP ribose polymerase inhibitor PJ34 to inhibit triple negative breast cancer cell growth
2019 · Jonathan V. Wooten, Nicole Mavingire, et al. · Cancer Research
Abstract 1304: Aryl hydrocarbon receptor ligands 5F 203 and 3,3'-Diindolylmethane disrupt mammospheres derived from MCF-7 cells and induce tumor suppressor miR125b-2 expression
2019 · Eileen Brantley, Nicole Mavingire, et al. · Cancer Research
Abstract 16: 3,3'-diindolylmethane induces cytoglobin expression and synergizes with poly ADP ribose polymerase inhibitor PJ34 to inhibit triple negative breast cancer cell growth
2019 · Jonathan V. Wooten, Nicole Mavingire, et al. · Cancer Chemistry
Abstract 1304: Aryl hydrocarbon receptor ligands 5F 203 and 3,3'-Diindolylmethane disrupt mammospheres derived from MCF-7 cells and induce tumor suppressor miR125b-2 expression
2019 · Eileen Brantley, Nicole Mavingire, et al. · Experimental and Molecular Therapeutics
Works count: 23
Citation count: 167
H-index: 6
I10-index: 5
Year
Topic
Type